Everett Harris & CO Merck & Co., Inc. Transaction History

Everett Harris & CO

  • $8 Billion
  • Q3 2024

A detailed history of Everett Harris & CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, Everett Harris & CO holds 184,986 shares of MRK stock, worth $18.3 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
184,986
Previous 175,746 5.26%
Holding current value
$18.3 Million
Previous $21.8 Million 3.45%
% of portfolio
0.26%
Previous 0.28%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024
BUY
$111.15 - $128.97 $1.03 Million - $1.19 Million
9,240 Added 5.26%
184,986 $21 Million
Q2 2024

Aug 01, 2024
SELL
$123.8 - $132.96 $148,436 - $159,419
-1,199 Reduced 0.68%
175,746 $21.8 Million
Q1 2024

Apr 19, 2024
BUY
$113.24 - $131.95 $164,877 - $192,119
1,456 Added 0.83%
176,945 $23.3 Million
Q4 2023

Jan 18, 2024
BUY
$100.18 - $109.02 $841,311 - $915,549
8,398 Added 5.03%
175,489 $19.1 Million
Q3 2023

Oct 23, 2023
BUY
$102.95 - $114.33 $124,775 - $138,567
1,212 Added 0.73%
167,091 $17.2 Million
Q2 2023

Jul 26, 2023
SELL
$108.61 - $118.38 $154,008 - $167,862
-1,418 Reduced 0.85%
165,879 $19.1 Million
Q1 2023

Apr 24, 2023
BUY
$102.94 - $114.86 $239,953 - $267,738
2,331 Added 1.41%
167,297 $17.8 Million
Q4 2022

Jan 20, 2023
SELL
$87.44 - $112.11 $1.19 Million - $1.53 Million
-13,621 Reduced 7.63%
164,966 $0
Q3 2022

Oct 21, 2022
BUY
$84.53 - $94.96 $117,750 - $132,279
1,393 Added 0.79%
178,587 $15.4 Million
Q2 2022

Jul 22, 2022
SELL
$83.49 - $94.64 $150,949 - $171,109
-1,808 Reduced 1.01%
177,194 $16.2 Million
Q1 2022

Apr 22, 2022
BUY
$73.51 - $82.4 $1.24 Million - $1.39 Million
16,870 Added 10.41%
179,002 $14.7 Million
Q4 2021

Feb 02, 2022
BUY
$72.28 - $90.54 $3.05 Million - $3.82 Million
42,224 Added 35.21%
162,132 $12.4 Million
Q3 2021

Nov 03, 2021
BUY
$71.68 - $78.83 $4.39 Million - $4.83 Million
61,247 Added 104.41%
119,908 $9.01 Million
Q2 2021

Jul 29, 2021
BUY
$70.31 - $77.77 $359,354 - $397,482
5,111 Added 9.54%
58,661 $4.56 Million
Q1 2021

May 13, 2021
BUY
$68.86 - $81.11 $76,503 - $90,113
1,111 Added 2.12%
53,550 $4.13 Million
Q4 2020

Feb 04, 2021
BUY
$71.77 - $79.65 $20,741 - $23,018
289 Added 0.55%
52,439 $4.29 Million
Q3 2020

Nov 03, 2020
BUY
$73.18 - $82.95 $56,787 - $64,369
776 Added 1.51%
52,150 $4.33 Million
Q2 2020

Jul 29, 2020
SELL
$70.42 - $80.13 $3.61 Million - $4.11 Million
-51,270 Closed
0 $0
Q1 2020

Apr 29, 2020
BUY
$63.36 - $87.82 $1.27 Million - $1.76 Million
20,037 Added 64.15%
51,270 $3.95 Million
Q4 2019

Jan 27, 2020
SELL
$77.58 - $87.54 $19,860 - $22,410
-256 Reduced 0.81%
31,233 $2.84 Million
Q3 2019

Nov 06, 2019
SELL
$76.08 - $82.93 $2.37 Million - $2.58 Million
-31,105 Reduced 49.69%
31,489 $2.65 Million
Q2 2019

Aug 13, 2019
SELL
$69.84 - $81.59 $163,774 - $191,328
-2,345 Reduced 3.61%
62,594 $5.25 Million
Q1 2019

May 13, 2019
SELL
$69.58 - $79.36 $236,572 - $269,824
-3,400 Reduced 4.98%
64,939 $5.4 Million
Q4 2018

Feb 13, 2019
SELL
$65.24 - $75.71 $23,160 - $26,877
-355 Reduced 0.52%
68,339 $5.22 Million
Q3 2018

Nov 14, 2018
BUY
$57.69 - $67.84 $298,199 - $350,664
5,169 Added 8.14%
68,694 $4.87 Million
Q2 2018

Jul 27, 2018
SELL
$50.83 - $59.72 $94,696 - $111,258
-1,863 Reduced 2.85%
63,525 $3.86 Million
Q1 2018

Apr 20, 2018
BUY
$50.96 - $59.23 $344,183 - $400,039
6,754 Added 11.52%
65,388 $3.56 Million
Q4 2017

Feb 01, 2018
SELL
$51.62 - $61.64 $38,715 - $46,230
-750 Reduced 1.26%
58,634 $3.3 Million
Q3 2017

Oct 11, 2017
BUY
$58.67 - $63.13 $3.48 Million - $3.75 Million
59,384
59,384 $3.8 Million

Others Institutions Holding MRK

# of Institutions
3,820
Shares Held
1.88B
Call Options Held
15.6M
Put Options Held
13.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Everett Harris & CO Portfolio

Follow Everett Harris & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Everett Harris & CO , based on Form 13F filings with the SEC.

News

Stay updated on Everett Harris & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email